UK markets closed

PureTech Health plc (PRTC)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
28.50-0.34 (-1.18%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 766.98M
Enterprise value 440.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)472.34
Price/book (mrq)1.51
Enterprise value/revenue 259.22
Enterprise value/EBITDA -12.26

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 30.56%
S&P500 52-week change 329.57%
52-week high 333.07
52-week low 317.08
50-day moving average 325.35
200-day moving average 324.62

Share statistics

Avg vol (3-month) 33.66k
Avg vol (10-day) 32.36k
Shares outstanding 527M
Implied shares outstanding 627.39M
Float 8154.84M
% held by insiders 10.00%
% held by institutions 10.04%
Shares short (15 Mar 2024) 44.17k
Short ratio (15 Mar 2024) 41.02
Short % of float (15 Mar 2024) 4N/A
Short % of shares outstanding (15 Mar 2024) 40.02%
Shares short (prior month 15 Feb 2024) 44.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,417.84%

Management effectiveness

Return on assets (ttm)-14.24%
Return on equity (ttm)-7.22%

Income statement

Revenue (ttm)11.74M
Revenue per share (ttm)0.42
Quarterly revenue growth (yoy)-55.20%
Gross profit (ttm)N/A
EBITDA -168.16M
Net income avi to common (ttm)-47.01M
Diluted EPS (ttm)-1.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)350.52M
Total cash per share (mrq)1.27
Total debt (mrq)129.3M
Total debt/equity (mrq)25.41%
Current ratio (mrq)7.31
Book value per share (mrq)1.86

Cash flow statement

Operating cash flow (ttm)-156.68M
Levered free cash flow (ttm)-185.74M